The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Health
·
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Health
If you’re over 55 and too tired to make it into the office, these two Fair Work decisions are required reading | Van Badham
The industrial tribunal is where the human experience of fatigue and the mythologies of outdated management cultures are...
CitrixNews Staff
·
59 minutes ago
Health
The Fix
Two former addicts run a church in Burnley trying to help people in crisis.
CitrixNews Staff
·
5 hours ago
Health
Rise in accidents involving kids and e-bikes sparks debate about regulation
Children's Health Rise in accidents involving kids and e-bikes sparks debate about regulation October 12, 20266:08 PM...
CitrixNews Staff
·
5 hours ago
Health
I've woken from operations to find the surgery hasn't been done - women's health is broken
Image caption, Kelly O'Shea has lived in chronic daily pain for the last three and a half years ByJenny ReesWales h...
CitrixNews Staff
·
6 hours ago